Loading
Biocon Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Biocon India Limited Employees Welfare Trust, was filed 02 Jun 2022.
Insider Decl.
268
Thresholds
n/a
Buy Volume
€8M
3 ops. · all time
Sell Volume
€4M
100 ops. · all time
Who traded when
BuySaleMylan Inc.1 sale
Since the insiders bought
- -24.6%Entry ₹320.30 · Close at T+365 ₹241.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Biocon Limited Buy (bullish), based on 19 analysts. Average price target: ₹440.68.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 18,364 of 26,280 companies
38.2
score / 100
Value33
Quality44
FCF yld0.2%
Earn yld0.7%
EV/EBITDA20.3x
ROE1.1%
Gross mgn66%
Net mgn2.3%
Debt/EBITDA4.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹336.00
Analyst consensus
19 analystsBuy
₹326.00Target ₹440.68(+31%)₹534.00
Income statement
Revenue₹167.8B
Gross profit₹110.9B66% margin
EBITDA₹33.7B20% margin
Net income₹3.9B2.9% margin
Valuation
PER (trailing)99.4x
PER (forward)30.7x
P/Book1.6x
Beta0.32
Balance sheet & cash
Market cap₹550.3B
Total debt₹154.3B
Free Cash Flow₹823M
Debt / Equity42%
Profitability & ownership
ROE1.1%
ROA1.7%
% insiders48.1%
% institutions31.9%
Last declaration on 31 July 2026
Declarations268 total
91,967,019 shares-MarketSEBI:663e90622d4f9daaf41036d823bb91c5c37dad56
61,827 shares@ ₹256.6016.1% of flowEquity SharesSEBI:d33423a0ae50c4940d55377ef2ebf5b3f1994265
7,328 shares@ ₹256.6020.6% of flowEquity SharesSEBI:c78f095209f404792fd65f44b2c74f009929367e
19,998 shares@ ₹264.3449.4% of flowEquity SharesSEBI:c5839accdeefcf11dbce01d25734d202a6bb77f5
11,000 shares@ ₹260.5511.9% of flowEquity SharesSEBI:ed16c3fd0c3b26e381e0866cdacdf32892ac94ed
6,792 shares@ ₹251.65100.0% of flowEquity SharesSEBI:8c02a46ef9e9423c1c87d009b7223b85c370dd1c
1,000 shares@ ₹275.800.7% of flowEquity SharesSEBI:c8faefb6f687fedbbd2bd70e9c52d31f245f90fa
2,000 shares@ ₹270.951.3% of flowEquity SharesSEBI:ed4c1879ec720ca56279261cbcb527ab0623aa97
5,000 shares@ ₹283.003.4% of flowEquity SharesSEBI:7232bad934bf214da087dd015e0eabf8cfedd242
20,500 shares@ ₹274.55100.0% of flowEquity SharesSEBI:1dc30af5c2b2bda027dd78ecc0f7201ae33dcf8c
1,000 shares@ ₹277.350.7% of flowEquity SharesSEBI:0f67abf84d1abf1a8100e4c3baa4aec831e28dfe
1,000 shares@ ₹278.550.7% of flowEquity SharesSEBI:8c72120d5d04071253ec5e5e6b5eb2eb855cde30
2,000 shares@ ₹279.201.3% of flowEquity SharesSEBI:fa3811b1d532f786d15662e39554072f8dbca8cc
1,000 shares@ ₹277.500.7% of flowEquity SharesSEBI:6425d6aa8d074f3e64f9598813600bf3d19563b5
5,000 shares@ ₹272.503.2% of flowEquity SharesSEBI:68ae0f0041478b87778fbe50351ed7a2f775661c
2,000 shares@ ₹270.451.3% of flowEquity SharesSEBI:19d39aa5e7b35b616b3e7dca35b0178811a620e8
1,000 shares@ ₹271.050.7% of flowEquity SharesSEBI:07a977f84876cf829f0ee8fed71af8bcf4a5651c
3,000 shares@ ₹269.182.0% of flowEquity SharesSEBI:408a5483dc17e22ad22a6f5203faa4780d60d492
5,944 shares@ ₹249.599951.3% of flowEquity SharesSEBI:445c651aaa33be3b246ec5f3ae1539cf00efd8d9
36,000 shares@ ₹248.52524.5% of flowEquity SharesSEBI:fb9f062186e70566c08ac2b200d406d5d13f026f
8,007 shares@ ₹248.525100.0% of flowEquity SharesSEBI:b5b7c42d85acb43edb8dcb2f9bc0cb6a4d5a5eba
4,980 shares@ ₹248.525123.9% of flowEquity SharesSEBI:50c8c5bdda04c372615367c7790c7336db7f49e2
2,000 shares@ ₹246.251.2% of flowEquity SharesSEBI:ab85a60903abea137b410ce909048f44ab90ed1c
2,000 shares@ ₹249.681.2% of flowEquity SharesSEBI:2e5c1d16262dd65df0a62a4a844a818c68cc94c9
3,000 shares@ ₹254.751.8% of flowEquity SharesSEBI:ce9fce6fdcfa0c1b3007731ef1b22b0a907ba0dd
25 of 268 declarations
About Biocon Limited
Biocon Limited produced 268 filings, including 148 grants and 100 sales worth EUR 3,523,292, with a median of EUR 22,230. Purchases number only 3, but they weigh more: EUR 7,755,056, median EUR 1,579,173, all by the Biocon India Limited Employees Welfare Trust (EUR 5,487,435 on June 2, 2022, EUR 1,579,173 on May 26 and EUR 688,448 on May 25, 2022).
This Indian Healthcare company, listed on the Bombay Stock Exchange and valued at INR 550.3 billion, has 82 filers, who hold 48.1% of the capital. Maneesh H Ghildyal filed 24 filings, 23 of them sales, Amitava Saha 20, 12 of them sales. The largest sale, EUR 308,479 on December 21, 2022, is by Ramakrishnan M S, who also sold EUR 156,522 on December 12 and EUR 155,162 on December 14.
Read moreShow less
Volume reaches 105 filings in 2023 and 74 in 2022, against 18 in 2024 and one in 2026. Publication happens on the same day at the median, and the only filing of the last twelve months is a sale.
